Gsrx Industries Inc · OTC:GSRX

Gsrx Industries — Investor Presentation (July 2018)

23 slides from Gsrx Industries's investor presentation, Jul 18, 2018

  1. Slide 1: 2018 Update (V 2.0)

    2018 UPDATE (V 2.0) OTCQB: GSRX GSRX TNOUSTRIES ZA SPRL SPIRULINEX ] gf 1a ' >= Sanu DB ass ‘Yi pal ULINEX<

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements The information on this presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate _ strictly to historical or current facts. Forward-

  3. Slide 3: Corporate Overview

    Corporate Overview GSRX Industries Inc. is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products. To date, GSRX has acq

  4. Slide 4: Experienced Management Team

    Experienced Management Team Les Ball, CEO GSRX Previously served as CEO/President of Corral West Ranchwear, expanding to 140 locations in US; President at Montgomery Ward; 22 years at RH. Macy, incl. President Macy's East, President Macy's Wholesale, President Macy's South, and Chairman/CEO of Macy'

  5. Slide 5: Board of Directors

    Board of Directors Christian Briggs Chairman of the Board Mr. Christian Briggs co-founded Cinsay Inc. ("Cinsay") in 2007, which is engaged in the development of an interactive advertising, marketing and e-commerce video platform. From 2009 to 2016, Mr. Briggs served as Chairman of the Board of Direc

  6. Slide 6: Board of Advisors

    Board of Advisors Luis F. Toledo-Bayouth A security specialist with more than 20 years’ experience, Toledo-Bayouth began his career as a Special Agent for the U.S. Drug Enforcement Administration in Miami. He returned to Puerto Rico, where he was Director of Security & Loss Prevention for Olympic Mi

  7. Slide 7: Expanding Operations in Key Markets

    Expanding Operations in Key Markets GSRX entered into Puerto Rico’s burgeoning medical cannabis dispensary marketplace with a goal to acquire, develop, and maintain medical cannabis dispensaries throughout the island in dense, populated areas and close to the island’s best hotels. Today, GSRX has ei

  8. Slide 8: Highlights

    Highlights = $75 billion dollar market opportunity by 2030 (Cowen & Co.) = Experienced management team = Plans for expansion into other medical and/or adult use markets through acquisitions/JVs with existing operations and experienced operators = Building vertically integrated business; from cultiva

  9. Slide 9: Highlights

    Highlights The cannabis market is already bigger than the major commodity markets, including coffee, iron, aluminum, and wheat. And, it's on track to becoming bigger than gold. As demand continues to rise, GSRX plans to expand on its operations in key markets. $2008 $180B $160B $1408 $120B $100B $80

  10. Slide 10: Cultivation, Extraction & Processing, Manufacturing, Retail

    ¢ SPRL SPIRULINEX ain a) a += =, : Fim SPIRULINE< di sscnnsone ‘yl MANUFACTURING RETAIL CULTIVATION EXTRACTION & ROCESSING

  11. Slide 11: California Opportunity

    California Opportunity + California is the most populous state in the United States with a population of 39.3 million residents. California's $2.67 trillion economy is larger than any state. * California sales have grown from $444 million in medical for 2013 to a projected $6.6 billion of combined m

  12. Slide 12: Growing & Cultivation

    Growing & Cultivation Sunset Connect GSRX has committed to invest up to $1M in join venture with boutique cultivation operator and branded extractions business headquartered in San Francisco Bay Area. = Sunset Connect Oakland, LLC (“Sunset”) is subleases 25,000 sq. ft. of space and is largest tenant

  13. Slide 13: Extraction & Processing

    Extraction & Processing a GREEN SPIRIT Ess GSRX is in early stages of manufacturing operations through its majority-owned subsidiaries at its new facility located in the heart of San Francisco. Using state of the art equipment in its operations, GS Essentials will process extractions into a variety

  14. Slide 14: Manufacturing: Spirulinex

    Manufacturing SPIRULINEX, HIGHLY SCIENTIFIC = GSRX has committed to invest up to $750K in join venture in Spirulinex, LLC, an extraction and processing company based in San Francisco that has developed a broad slate of cannabinoid ingestibles. = Spirulinex commenced operations in California in Decem

  15. Slide 15: Manufacturing: DragonGlass

    Manufacturing: DragonGlass SPIRULINX HIGHLY SCIENTIFIC = Developer of Dragonglass (a.k.a Flake & Bake), the company's proprietary patent pending formula. = All-natural, vegan and gluten free = Zero Calorie. Zero Alcohols. Zero Fat. DRAGONGLASS” — FLAKE& BAKE = CANNABIS-INFUSED =©=—-GET CREATIVE GSRX

  16. Slide 16: California Operations Flow Chart

    California Operations Flow Chart 55% ownership 51% ownership 55% ownership PRODUCT & SALES PRODUCT & SALES Inc. | OTCQB: GSRX Version 2.0

  17. Slide 17: California Dispensary Operations

    California Dispensary Operations = GSRX plans to acquire more dispensary operations with significant growth potential in key markets across California = First dispensary acquired in Point Arena in 2018 = Adult-use sales, which began Jan. 1, expected to drive market to $6.6B annually in 2018 (beer sa

  18. Slide 18: Puerto Rican Operations

    Puerto Rican Operations Americas), but is also currently one of the only Caribbean islands where cannabis has been legalized for medicinal purposes. Anyone with medical-issued license from another state may purchase cannabis by filling out a legal form (same day turnaround) Puerto Rico's rate of tou

  19. Slide 19: Early-Mover Advantage in Puerto Rico

    Early-Mover Advantage in Puerto Rico = Economics could accelerate addition of adult-use. = Puerto Rico has reciprocating agreement with medical cannabis cardholders from other states; an estimated 10 million tourists visited the island in 2016. The 2018/2019 cruising season is expected to witness a

  20. Slide 20: US Cannabis Growth Rates

    US Cannabis Growth Rates WASHINGTON MARIJUANA SALES GROWTH ‘CALIFORNIA MARLJUANA SALES GROWTH COLORADO MARIJUANA SALES GROWTH $1.18 gigp $228 $814M ene $576M MEDEA $4om a oe sagt SS 2013 2014 «2015 «2016 =2017 2015 2016 2017 2013 2014 2015 Figure 3 Young Adult Alcohol Incidence on the Decline Acohol

  21. Slide 21: PR Cannabis Growth Rates

    PR Cannabis Growth Rates PUERTO RICO ESTIMATED CANNABIS SALES GROWTH 2018: 48k Medical cards x $15k/year $1.8B 2019: 125k Medical cards x $15k/year [ 2019/2020

  22. Slide 22: Industry Comps

    Industry Comps Company Name Ticker Price Close Market Cap Revenue (ttm) P/s (ttm) Aphria Inc. APHQF 9.05 $2.13B $20.44M 104.20 Aurora Cannabis Inc. ACBFF 6.85 $3.93B $15M 240x Cannagrow Holdings Inc. CGRW 1.27 $133.72M $1.66M 80.55x Canopy Growth Corporation TWMIF 30.21 $6.011B $39.9M 150.65x Cronos

  23. Slide 23: Corporate Contact

    GS RX 2048 UPDATE (V 2.0) OTC: GSRX CORPORATE CONTACT. Thomas Gingerich Chief Financial Officer Building No. 3, P. R. 696 Int. Jose Efron Ave. Dorado, PR, 00646 +1 (214) 808-8649 tom@greenspiritrx.com GREEN SPIRIT RX - Puerto Rico www.greenspiritrx.com Instagram @GreenSpiritRX The Green Room Dispens

GSRX Industries — Investor Presentation (July 2018) on 6ix